Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort

Objective To assess the effectiveness of belimumab (BEL) in improving anaemia, thrombocytopenia, lymphopenia and leucopenia in patients with SLE.Methods The BeRLiSS (Belimumab in Real Life Setting Study) 2.0 cohort included patients with SLE from 14 Italian referral centres treated with BEL for acti...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Alessandra Bortoluzzi, Andrea Doria, Marcello Govoni, Alberto Cauli, Matteo Piga, Roberta Ramonda, Margherita Zen, Luca Iaccarino, Lorenzo Cavagna, Carlo Salvarani, Roberto Gerli, Giovanni Orsolini, Maurizio Rossini, Giacomo Emmi, Luca Quartuccio, Maria Letizia Urban, Ettore Silvagni, Mariele Gatto, Elisabetta Chessa, Elena Silvestri, Simone Negrini, Paola Tomietto, Marco Di Carlo, Giulia Pazzola, Rossella De Angelis, Alberto Lo Gullo, Filippo Vesentini, Federico Arru, Roberto Depascale, Emanuele Chiara, Isotta Galvagni, Luisa Brussino, Greta Hulej, Benedetta Bianchi, Paola Castrignanò, Ginevra De Marchi, Michela Gasparotto, Alessia Nano, Silvia Noviello, Marianna Tamussin, Martina Tizian, Angelo Vacca, Marisol Bracalenti
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMJ Publishing Group 2026-05-01
سلاسل:	Lupus Science and Medicine
الوصول للمادة أونلاين:	https://lupus.bmj.com/content/13/1/e001934.full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!